B

BetterHelp

D2C and B2B online therapy platform

Overview

BetterHelp offers online mental health services through a subscription model, giving users access to licensed therapists via messaging, phone calls, or video sessions. Subscribers pay a recurring fee to receive ongoing counseling, and the company also serves the business-to-business market by providing mental health support to employees of partner companies. Backed by Teladoc Health, it combines direct-to-consumer and employer-focused offerings within a scalable telehealth platform. Its goal is to make mental health care more accessible and affordable for individuals and workers at scale.

Significant Headcount Growth

Work here?Claim your company

About BetterHelp

Simplify's Rating
Why BetterHelp is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Consumer SoftwareEnterprise SoftwareHealthcare

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

$4.5M

Headquarters

San Francisco, CA

Founded

2013

Get referred to BetterHelp

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Q3 2026 insurance revenue hit $32 million, up sharply and above management’s range.
  • Teladoc targets $200 million annualized BetterHelp insurance revenue exiting 2027, supporting stabilization.
  • Recent partnerships with Spotify and Billboard expand brand trust and acquisition at lower ad spend.

What critics are saying

  • The FTC privacy case still shadows BetterHelp after the 2024 $7.8 million settlement.
  • California class actions over advertiser data sharing still proceed, extending discovery and legal costs into 2027.
  • Cash-pay revenue fell 12.8% in Q3 2026; prolonged declines can crush BetterHelp’s core business.

What makes BetterHelp unique

  • BetterHelp is Teladoc’s largest online therapy brand, with 30,000 therapists and 100-plus countries.
  • Its insurance pivot differentiates it from cash-pay peers, with 27,000 covered sessions weekly.
  • Billboard, Spotify Fresh Finds Forward, and sports activations extend consumer reach beyond therapy.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$4.5M

Above

Industry Average

Funded Over

1 Rounds

Acquisition funding comparison data is currently unavailable. We're working to provide this information soon!
Acquisition Funding Comparison Coming Soon

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Company Match
  • Remote Work Options
  • Flexible Work Hours
  • Employee Stock Purchase Plan

Growth & Insights and Company News

6 month growth

3%

1 year growth

24%

2 year growth

28%
Flywheel Publishing, LLC
Oct 29th, 2026
Teladoc soars 26% as revenue and profit beat estimates; Hims & Hers Health and American Well tick up.

Teladoc soars 26% as revenue and profit beat estimates; Hims & Hers Health and American Well tick up. Teladoc posted falling revenue yet still managed to beat Wall Street on both sales and profit, sending shares surging. The real question is whether a surprising shift inside its BetterHelp unit can turn a struggling business into a growth story. Shrinking revenue hasn't kept Teladoc Health (NYSE:TDOC) from beating estimates on both sales and earnings. Early signs that its BetterHelp mental health business can shift toward insurance-covered care are giving investors a reason to bid the stock up significantly. Teladoc stock is at $8.76, up 26% around midday. Taking a look at Teladoc Health's peers, Hims & Hers Health (NYSE:HIMS) stock is at $29.89, up 2%. American Well (NYSE:AMWL) stock is at $14.21, up 0.64%. Teladoc beats on revenue and profit as BetterHelp shifts to insurance. Key data−. Previous Close Market Cap Day's Range 52wk Range Dividend Yield After the close on October 28, Teladoc Health reported Q3 2026 results showing revenue fell 3% to $605.1 million, exceeding the $588.4 million analyst consensus. On the bottom line, Teladoc Health posted a net loss of $0.15 per share, smaller than the Wall Street analysts' consensus loss of $0.21. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) at Teladoc Health rose 14% to $79.4 million, ahead of the Wall Street analysts' consensus of $68.08 million. Within the business, Teladoc's Integrated Care segment revenue rose 2% to $398.5 million with an adjusted EBITDA margin of 18.8%, up from 17%, while BetterHelp revenue fell 13% to $206.6 million as fewer users paid out of pocket. BetterHelp's insurance-covered services revenue reached $32.1 million, up from $3.7 million a year earlier. Teladoc CEO Chuck Divita said, "We delivered third quarter results near the upper end of our guidance range for consolidated revenue and above our range for consolidated adjusted EBITDA, reflecting solid execution across our two segments." Divita added, "In the BetterHelp segment, insurance revenue exceeded our expectations, and we are making encouraging progress expanding provider capacity and scaling access to covered services." For the full year, Teladoc Health expects adjusted EBITDA of $277 million to $303 million. Still, Teladoc Health's Q4 2026 revenue outlook midpoint of $592 million trailed the Wall Street analysts' consensus of $596.6 million. Why Teladoc is pulling away from American Well and Hims & Hers. Teladoc stock is now up 25% year to date (YTD) following the jump. The closest platform comparable is American Well, which sells virtual care to health plans and health systems. Shares of American Well are up 189% YTD. Despite that run, American Well is only inching higher as Teladoc rises. Free Report, Just Released Why Didn't HIMS Make The Top 10 List? 24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now. And HIMS didn't make the cut! The report is free, and you can see why we think each stock is a top investment today. American Well operates as a business-to-business software vendor, selling Amwell Converge, SilverCloud and Carepoint subscriptions to payers, providers and the Defense Health Agency. That setup leaves American Well without a direct-to-consumer therapy arm, so it carries no cash-pay decline of the kind weighing on BetterHelp. Hims & Hers runs a consumer cash-pay telehealth platform built on its own branded products, and the stock is down 8% this year. The company is moving its U.S. weight-loss offering toward branded glucagon-like peptide-1 (GLP-1) medications. Such a cash-pay model runs opposite to Teladoc's effort to put BetterHelp therapy under insurance coverage. Physician tools maker Doximity (NYSE:DOCS | DOCS Price Prediction) is at $34.11, down 0.41%. Year to date, Doximity is down 23%, trailing Teladoc Health. Across the sector, the Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is at $183.48, up 2%, a far smaller gain than Teladoc Health's. Can Teladoc turn insurance gains into revenue growth? Teladoc still faces a key question: whether insurance-covered BetterHelp revenue grows fast enough to offset the cash-pay decline. Teladoc's management is aiming for an annualized BetterHelp insurance revenue run rate of at least $200 million exiting 2027, while Divita noted the company expects "ongoing challenges in cash pay going forward." Teladoc's wider Integrated Care margin and a fourth consecutive quarterly earnings beat give bulls reason for hope. The bears can cite a shrinking BetterHelp paying-user base and $997.6 million of convertible senior notes now classified as current. A return to companywide revenue growth would require the insurance ramp to outpace that cash-pay erosion. Investors may want to track how the BetterHelp insurance transition develops over the coming quarters. Got $1,000? Before you buy HIMS, read this. If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And HIMS wasn't one of them. They combed the entire market. It's not 10 ideas, not 10 stocks everyone is talking about, it's what their research points to as the 10 best stocks to buy right now, and it's free. Read more here and see which stocks made the list ->> David Moadel David Moadel is financial writer specializing in stocks, ETFs, options, precious metals, and Bitcoin. David has written well over 1,000 articles for leading online publications, helping investors understand markets, income strategies, and risk.His work has appeared in The Motley Fool, InvestorPlace, U.S. News & World Report, TipRanks, ValueWalk, Benzinga, Market Realist, TalkMarkets, Finmasters, 24/7 Wall St., and others.With a master's degree in education, David has taught at the elementary, high school, and college levels. That teaching background shapes his writing style: clear, educational, and practical. David has also built a loyal social-media audience by providing trustworthy financial content on YouTube, X/Twitter, and StockTwits.

Yahoo Finance
Oct 29th, 2026
Teladoc Q3 revenue falls 3.4% to $605M as BetterHelp insurance growth offsets cash-pay slump

Teladoc Health reported third-quarter revenue of $605 million, down 3.4% from a year earlier, as growth in Integrated Care and BetterHelp insurance offset weaker BetterHelp cash-pay sales. Adjusted EBITDA rose 13.5% to $79 million, and the net loss narrowed to $0.15 per share from $0.28. Integrated Care revenue rose 2.3% to $398 million. BetterHelp revenue fell 12.8% to $207 million, though its insurance revenue reached $32 million, up $10 million from the previous quarter. Teladoc raised its 2026 revenue outlook to $2.39 billion to $2.44 billion. It also plans to address $1 billion in convertible notes due June 2027, possibly by repurchasing a large share before year-end.

MarketBeat
Oct 28th, 2026
Teladoc Health (NYSE:TDOC) announces quarterly earnings results, beats estimates by $0.07 EPS.

Teladoc Health (NYSE:TDOC) announces quarterly earnings results, beats estimates by $0.07 EPS. October 28, 2026 Key points. * Teladoc beat quarterly expectations: Revenue reached $605.1 million versus the $588.1 million consensus, while its $0.15 per-share loss was $0.07 narrower than expected. Adjusted EBITDA rose 13.5% year over year to $79 million, and the stock gained 6.5%. * Integrated Care showed improvement, with 2.3% revenue growth and an 18.8% adjusted EBITDA margin, prompting the company to raise its full-year margin outlook. BetterHelp's insurance business also expanded, although total BetterHelp revenue fell 12.8% as cash-pay demand weakened. * Challenges remain: Teladoc continues to report net losses, expects further BetterHelp cash-pay weakness, and forecast fourth-quarter revenue of $569 million to $615 million - slightly below Wall Street expectations at the midpoint. * Interested in Teladoc Health? Here are five stocks we like better. Teladoc Health (NYSE:TDOC - Get Free Report) released its earnings results on Wednesday. The health services provider reported ($0.15) earnings per share for the quarter, topping analysts' consensus estimates of ($0.22) by $0.07, FiscalAI reports. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The firm had revenue of $605.10 million during the quarter, compared to analyst estimates of $588.13 million. Here are the key takeaways from Teladoc Health's conference call: * Third-quarter results exceeded expectations: Revenue was $605 million, near the high end of guidance, while adjusted EBITDA rose 13.5% year over year to $79 million, with margin expanding to 13.1%. * Integrated Care delivered 2.3% revenue growth and an 18.8% adjusted EBITDA margin, supported by double-digit international growth, higher chronic-care enrollment, and productivity improvements. The company raised its full-year Integrated Care margin outlook to 16.0%-16.6%. * BetterHelp's insurance transition is gaining traction, with insurance revenue reaching $32 million, weekly insurance-covered sessions rising to 27,000, and more than 11,000 credentialed therapists. Management is targeting an annualized insurance revenue run rate of at least $200 million exiting 2027. * BetterHelp's overall revenue declined 12.8% year over year as cash-pay demand remained pressured, and management expects continued cash-pay weakness as advertising spending is reduced further. Full-year BetterHelp revenue is now expected to decline 12.9%-16.1% from 2025, with lower margins due to insurance mix and related investments. * Teladoc One and the Teledine Health acquisition are intended to expand comprehensive virtual care and U.S. hospital hybrid-care opportunities, but broader Teladoc One availability is not expected until 2027. The company also plans to address the $1 billion convertible-note maturity through potential debt financing, cash, and note repurchases, subject to market conditions. Teladoc Health stock up 6.5%. Teladoc Health stock traded up $0.42 during trading hours on Wednesday, hitting $6.87. The stock had a trading volume of 8,586,863 shares, compared to its average volume of 5,024,669. The company has a 50-day moving average of $6.14 and a two-hundred day moving average of $6.46. Teladoc Health has a fifty-two week low of $4.40 and a fifty-two week high of $9.89. The company has a market cap of $1.25 billion, a PE ratio of -6.94 and a beta of 2.14. Insider buying and selling at Teladoc Health. In related news, CEO Charles III sold 17,805 shares of the company's stock in a transaction on Friday, September 11th. The stock was sold at an average price of $6.10, for a total value of $108,610.50. Following the completion of the transaction, the chief executive officer directly owned 465,535 shares in the company, valued at approximately $2,839,763.50. This represents a 3.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.70% of the company's stock. More Teladoc Health news. Here are the key news stories impacting Teladoc Health this week: * Teladoc reported third-quarter revenue of $605.1 million, exceeding the $588.1 million analyst consensus. The company's net loss of $0.15 per share was also narrower than the expected $0.22 loss, providing the main catalyst for the stock's advance. * The earnings release indicated that Teladoc continued to reduce the size of its quarterly loss, potentially reinforcing expectations that cost controls and operating improvements can support future cash generation. * Management forecast fourth-quarter revenue of $569 million to $615 million, implying a midpoint of approximately $592 million. That outlook gives investors a clearer near-term range but was reported as slightly below Wall Street expectations. * Third-quarter revenue declined approximately 3% year over year, while Teladoc remained unprofitable, reporting a $26.9 million net loss and a negative net margin. The weak growth profile and continued losses could limit the durability of the positive reaction. Wall Street analyst weigh in. A number of research firms have recently commented on TDOC. Weiss Ratings reiterated a "sell (d-)" rating on shares of Teladoc Health in a research note on Wednesday, August 19th. Canaccord Genuity Group cut their price objective on Teladoc Health from $11.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, July 30th. Citigroup decreased their target price on Teladoc Health from $11.00 to $7.50 and set a "neutral" rating for the company in a research note on Monday, August 3rd. Finally, Bank of America raised their target price on Teladoc Health from $9.00 to $10.50 and gave the company a "buy" rating in a report on Tuesday, July 7th. Five equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $7.54. Teladoc Health company profile. Teladoc Health, Inc provides virtual healthcare services and technology designed to connect patients with medical professionals remotely. Through its digital platforms, the company supports a range of healthcare needs, including general medical consultations, mental health services, specialty care, and ongoing management of chronic conditions. Its offerings include telehealth visits with physicians and other licensed providers, behavioral health services through BetterHelp, and chronic care programs that use digital tools and clinical support to help people manage conditions such as diabetes and hypertension. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Teladoc Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list. While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you'll find 7 stocks that could play a major role in the next tech-driven market boom. Continue following MarketBeat

OrthoIndy
Sep 15th, 2026
WeShare Health and orthoindy collaborate to expand specialty care access in Indianapolis.

WeShare Health and orthoindy collaborate to expand specialty care access in Indianapolis. New collaboration offers providers clear verification and payment within two weeks while giving patients a new way to access comprehensive orthopedic care INDIANAPOLIS, Aug. 24, 2026 - Expanded access to high-quality orthopedic care is coming to Central Indiana individuals, families, and small businesses seeking an alternative to traditional health insurance. WeShare Health, a nonprofit healthcare sharing organization built to make healthcare simpler, more affordable, and more human, today announced a new collaboration with OrthoIndy, a leading orthopedic practice specializing in bone, joint, spine, and muscle care. Through the collaboration, WeShare Health members across Central Indiana will have access to OrthoIndy's comprehensive orthopedic services and specialists. The collaboration comes as WeShare Health continues to expand its presence in Indianapolis and serve those looking for an alternative to employer insurance and ACA plans. For OrthoIndy and other providers considering the WeShare Health network, the partnership is built on three fundamentals: clear member verification, a straightforward billing process, and payment for eligible medical expenses in less than 14 days, faster than most traditional insurers. WeShare Health is a nonprofit, faith-inspired organization where members contribute monthly to share one another's eligible medical expenses. WeShare Health exists to keep members healthy, and to support them when they're not. According to WeShare Health, members access a national network of more than 1 million physicians at 30 to 60 percent less than comparable traditional insurance. WeShare Health has served more than 100,000 members and shared more than $50 million in medical expenses. "We started WeShare Health because people deserve legitimate alternatives to traditional health insurance," said Christopher Jin, CEO of WeShare Health. "That same commitment extends to how we work with providers: clear processes, clear communication, and a partner they can count on. OrthoIndy is exactly the kind of relationship we're proud to build, and it's a model we intend to bring to more specialty providers across Indiana." "We're proud to take this step into the healthcare sharing space alongside WeShare Health because it creates another way for people in our community to access high-quality, comprehensive orthopedic care," said Dr. Matthew Lavery, president and CEO of OrthoIndy. "We want patients to have choices that work for them and their families. By working together with WeShare Health, we can help make OrthoIndy's orthopedic specialists and services accessible to more people across Central Indiana." "I've worked with OrthoIndy for years as a direct primary care physician in Indianapolis, and when I joined WeShare Health, OrthoIndy was the first referral partner I reached out to," said Dr. Jake DeWitt, Chief Medical Officer of WeShare Health. "I've seen firsthand the level of care they consistently provide. As WeShare Health expands its presence across Indiana, we're proud to formalize a relationship built on that same trust, giving our members a direct path to some of the best orthopedic care in the state." WeShare Health is actively expanding its Indianapolis provider network. Physicians, specialists, clinics, and health systems interested in joining can expect clear eligibility documentation, a defined coordination process, and consistent payment turnaround. To learn more about OrthoIndy and its comprehensive orthopedic services, visit orthoindy.com. About WeShare Health WeShare Health is a nonprofit healthcare sharing organization built to make healthcare simpler, more affordable, and more human. Members contribute monthly to share one another's eligible medical expenses. OrthoIndy partner with organizations like Noom, BetterHelp, and Amwell to help keep members healthy. When they're not, WeShare Health steps in to share costs. Founded in 2018, WeShare Health has served more than 100,000 members nationwide and shared more than $50 million in medical expenses. Members access a national network of more than 1 million physicians at 30 to 60 percent less than comparable traditional insurance. WeShare Health is rated 4.6 out of 5 on Google Reviews and is certified as a Great Place To Work(R) by its employees. Its purpose is clear: people before profit. For more information, visit www.weshare.org. About OrthoIndy OrthoIndy is one of the nation's most respected orthopedic practices, trusted for leading-edge bone, joint, spine and muscle care. OrthoIndy is a three-time recipient of the No. 1 ranking in Indiana for joint replacement by Healthgrades, one of several national and statewide honors recognizing its healthcare quality and patient experience. With more than 100 physicians, OrthoIndy continues to expand access to high-quality, affordable orthopedic care through initiatives such as the Designated Orthopedic Network with Anthem. OrthoIndy is the official orthopedic provider for the Indiana Pacers and Indiana Fever and the preferred provider for employees of the State of Indiana, Indianapolis Public Schools and the Metropolitan School District (M.S.D.) of Wayne Township. Learn more at OrthoIndy.com. Media Contacts WeShare Health Maddie Greer P: 765-480-1698

Teladoc Health
May 14th, 2026
BetterHelp joins Patient Safety Organization to advance quality and safety practices in virtual mental health care.

BetterHelp joins Patient Safety Organization to advance quality and safety practices in virtual mental health care. New partnership elevates care standards through new reporting, strengthening organization's ability to identify risks, learn from data, and advance better outcomes SAN JOSE, Calif.-BetterHelp, the world's largest online therapy platform, today announced its partnership with the Institute of Patient Safety and Quality of Virtual Care, a component Patient Safety Organization (PSO) of Teladoc Health, BetterHelp's parent company. Founded in 2019, The Institute of Patient Safety and Quality of Virtual Care is the first PSO dedicated to clinical quality and continuous improvement in virtual care. Federally recognized PSOs create a structured, protected environment where healthcare organizations can identify risks, analyze safety events, and share insights to prevent future harm. To encourage continuous improvement, healthcare providers receive certain legal protections so that the root causes of emerging issues can be identified and addressed quickly. BetterHelp's participation builds on the company's existing foundation of rigorous clinical standards and systems that monitor engagement signals and escalate potential concerns to licensed clinicians for structured review, enabling a level of safety and oversight that is difficult to achieve in traditional settings. "This partnership builds on our ongoing investments in quality that help us advance outcomes, improve matching, and expand access through insurance," said Dr. Russell DuBois, Vice President of Clinical Quality, Operations and Innovation at BetterHelp. "With a network of more than 30,000 therapists on our platform, supporting millions of people around the world, and strong outcomes data, BetterHelp is in a unique position to contribute meaningful learnings at scale, and translate those insights into improvements that strengthen clinical quality, empower therapists, and elevate care delivery." Through its participation in the PSO, BetterHelp is enhancing its ability to: * Strengthen patient safety and care quality by identifying new trends, uncovering process gaps, and driving continuous improvement * Enable more candid, insights-driven learning to continuously improve care delivery * Build a foundation for scalable, responsible growth, supporting broader partnerships across the healthcare ecosystem As a PSO participant, BetterHelp will be able to review systematic patterns and safety evaluations in its clinical data. This will help to identify new opportunities to enhance the quality of care, improve outcomes, and support a more responsive experience for both providers and patients. "As virtual mental health continues to expand, participation from organizations like BetterHelp in The Institute of Patient Safety and Quality of Virtual Care advances a learning-driven system that benefits both patients and providers by improving the quality of patient care delivery," said Peggy Binzer, Executive Director of the Alliance for Quality Improvement and Patient Safety. About BetterHelp BetterHelp was founded in 2013 to remove the traditional barriers to therapy and make mental health care more accessible to everyone. Today, it's the world's largest online therapy platform providing professional, affordable, and tailored therapy in a convenient online format. BetterHelp's network of 30,000 licensed therapists globally has helped millions of people worldwide take ownership of their mental health and work towards their personal goals. As the unmet need for mental health services persists, BetterHelp is committed to expanding access to therapy globally. About Teladoc Health Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners - transforming virtual care into a catalyst for how better health happens. Through its relationships with health plans, employers, providers, health systems and consumers, Teladoc Health, Inc. is enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com. For press and media inquiries, please email Teladoc Health, Inc. at [email protected] and be sure to follow Teladoc Health, Inc. on X and LinkedIn. Are you a member in need of assistance? Please contact: [email protected]

Recently Posted Jobs

Sign up to get curated job recommendations

BetterHelp is Hiring for 17 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs